T. Pollmacher et al., PLASMA-LEVELS OF CYTOKINES AND SOLUBLE CYTOKINE RECEPTORS DURING TREATMENT WITH HALOPERIDOL, The American journal of psychiatry, 154(12), 1997, pp. 1763-1765
Objective: Clozapine increases the levels of cytokines and soluble cyt
okine receptors. The authors investigated whether haloperidol has simi
lar effects. Method: Rectal temperature, white blood cell counts, and
plasma levels of cytokines and soluble cytokine receptors were assesse
d before and during 6 weeks of haloperidol treatment in 10 psychiatric
patients. Results: Haloperidol at mean doses of 7.0 mg/day (SD = 3.4)
, 6.9 mg/day (SD = 3.4), and 5.0 mg/day (SD = 3.1) at the end of the 1
st, 2nd, and 6th weeks of treatment, respectively, did not affect rect
al temperature, white blood cell counts, or plasma level of interleuki
n-l receptor antagonist, interleukin-6, tumor necrosis factor-alpha (T
NF-alpha), soluble TNF receptor p55 or p75, or soluble interleukin-2 r
eceptor. Conclusions: Haloperidol is unlikely to confound the results
of studies investigating disease-related alterations In the levels of
a broad range of cytokines and soluble cytokine receptors in schizophr
enia.